Danielle D'Emilia Decourcey, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attitude to Death | 6 | 2023 | 382 | 1.990 |
Why?
|
| Diabetic Ketoacidosis | 4 | 2020 | 245 | 1.790 |
Why?
|
| Terminal Care | 6 | 2021 | 1694 | 1.660 |
Why?
|
| Parents | 11 | 2023 | 3407 | 1.630 |
Why?
|
| Advance Care Planning | 4 | 2022 | 662 | 1.430 |
Why?
|
| Chronic Disease | 14 | 2023 | 9146 | 1.190 |
Why?
|
| Bereavement | 2 | 2021 | 277 | 1.160 |
Why?
|
| Brain Edema | 3 | 2017 | 617 | 1.090 |
Why?
|
| Death | 5 | 2023 | 678 | 1.040 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2014 | 110 | 0.900 |
Why?
|
| Mannitol | 2 | 2014 | 181 | 0.890 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2021 | 981 | 0.680 |
Why?
|
| Communication | 4 | 2022 | 3749 | 0.660 |
Why?
|
| Quality of Life | 3 | 2022 | 12804 | 0.520 |
Why?
|
| Medication Reconciliation | 1 | 2017 | 151 | 0.520 |
Why?
|
| Child | 24 | 2023 | 77709 | 0.480 |
Why?
|
| Palliative Care | 6 | 2023 | 3493 | 0.460 |
Why?
|
| Dyspnea | 1 | 2020 | 1303 | 0.420 |
Why?
|
| Poverty | 1 | 2023 | 2660 | 0.410 |
Why?
|
| Family | 2 | 2021 | 3147 | 0.370 |
Why?
|
| Cross-Sectional Studies | 9 | 2023 | 25043 | 0.360 |
Why?
|
| Critical Care | 2 | 2021 | 2647 | 0.320 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3336 | 0.270 |
Why?
|
| Emotions | 1 | 2017 | 2661 | 0.260 |
Why?
|
| Critical Illness | 1 | 2017 | 2670 | 0.250 |
Why?
|
| Hospitals, Pediatric | 3 | 2019 | 1775 | 0.250 |
Why?
|
| Physician-Patient Relations | 1 | 2017 | 3229 | 0.230 |
Why?
|
| Physicians | 1 | 2021 | 4567 | 0.220 |
Why?
|
| Child, Preschool | 9 | 2021 | 41006 | 0.220 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 15540 | 0.210 |
Why?
|
| Hospitalization | 1 | 2021 | 10262 | 0.200 |
Why?
|
| Infant | 8 | 2021 | 35136 | 0.200 |
Why?
|
| Humans | 31 | 2023 | 744343 | 0.190 |
Why?
|
| Adolescent | 10 | 2022 | 85781 | 0.180 |
Why?
|
| Technology | 1 | 2021 | 305 | 0.170 |
Why?
|
| Homocysteine | 2 | 1999 | 647 | 0.160 |
Why?
|
| Young Adult | 6 | 2022 | 56430 | 0.160 |
Why?
|
| Sulfhydryl Compounds | 1 | 1999 | 298 | 0.150 |
Why?
|
| Boston | 2 | 2020 | 9313 | 0.150 |
Why?
|
| Medicaid | 2 | 2021 | 2736 | 0.140 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2022 | 780 | 0.140 |
Why?
|
| Hospital Mortality | 2 | 2021 | 5317 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20129 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 13102 | 0.110 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1416 | 0.110 |
Why?
|
| Child Health Services | 1 | 2019 | 667 | 0.110 |
Why?
|
| Drug Utilization | 1 | 2019 | 1183 | 0.110 |
Why?
|
| Consciousness Disorders | 1 | 2017 | 418 | 0.110 |
Why?
|
| Health Resources | 1 | 2019 | 911 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2021 | 2682 | 0.110 |
Why?
|
| Head | 1 | 2017 | 880 | 0.100 |
Why?
|
| Drug Costs | 1 | 2019 | 1105 | 0.100 |
Why?
|
| Male | 11 | 2021 | 350118 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2022 | 1354 | 0.100 |
Why?
|
| Infant, Premature | 1 | 2020 | 2044 | 0.100 |
Why?
|
| Medication Errors | 1 | 2017 | 798 | 0.090 |
Why?
|
| Female | 12 | 2022 | 380194 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2021 | 1622 | 0.090 |
Why?
|
| Heart Diseases | 1 | 2023 | 2788 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2022 | 25625 | 0.090 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 1637 | 0.090 |
Why?
|
| Health Personnel | 1 | 2022 | 3218 | 0.080 |
Why?
|
| Cerebral Cortex | 4 | 1999 | 5708 | 0.080 |
Why?
|
| Retrospective Studies | 6 | 2021 | 77449 | 0.080 |
Why?
|
| Cause of Death | 1 | 2017 | 3584 | 0.070 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3864 | 0.070 |
Why?
|
| Cysteine Endopeptidases | 2 | 1998 | 563 | 0.070 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.060 |
Why?
|
| Massachusetts | 1 | 2017 | 8663 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2017 | 53288 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 19905 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 12245 | 0.060 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 6489 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2017 | 5102 | 0.050 |
Why?
|
| AIDS Dementia Complex | 1 | 2002 | 154 | 0.050 |
Why?
|
| N-Methylaspartate | 2 | 1998 | 231 | 0.050 |
Why?
|
| Neurons | 5 | 2002 | 9338 | 0.040 |
Why?
|
| Apoptosis | 3 | 2002 | 9727 | 0.040 |
Why?
|
| Caspases | 1 | 2002 | 928 | 0.040 |
Why?
|
| Adult | 5 | 2022 | 214055 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 132 | 0.040 |
Why?
|
| Polypharmacy | 1 | 2019 | 294 | 0.040 |
Why?
|
| Neurotoxins | 1 | 1997 | 237 | 0.030 |
Why?
|
| Neoplasms | 1 | 2023 | 21683 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 72290 | 0.030 |
Why?
|
| Cell Death | 1 | 1999 | 1706 | 0.030 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 687 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 3 | 1999 | 8301 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18370 | 0.030 |
Why?
|
| United States | 4 | 2022 | 69872 | 0.030 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 1997 | 895 | 0.030 |
Why?
|
| Cells, Cultured | 4 | 2002 | 19229 | 0.020 |
Why?
|
| Caspase 1 | 2 | 2002 | 224 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2022 | 3528 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1997 | 2132 | 0.020 |
Why?
|
| Rats | 3 | 1999 | 24260 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2021 | 40561 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1999 | 10943 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 213383 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2019 | 3209 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 163280 | 0.020 |
Why?
|
| Sex Factors | 1 | 2019 | 10397 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 13989 | 0.020 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 128 | 0.010 |
Why?
|
| Caspase 9 | 1 | 2002 | 188 | 0.010 |
Why?
|
| Caspase 8 | 1 | 2002 | 195 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 758 | 0.010 |
Why?
|
| Dendrites | 1 | 2002 | 485 | 0.010 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1998 | 68 | 0.010 |
Why?
|
| Lipid Peroxides | 1 | 1998 | 73 | 0.010 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1998 | 190 | 0.010 |
Why?
|
| Calcimycin | 1 | 1997 | 222 | 0.010 |
Why?
|
| Ionophores | 1 | 1997 | 108 | 0.010 |
Why?
|
| Nitroso Compounds | 1 | 1997 | 72 | 0.010 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 1997 | 58 | 0.010 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 1997 | 62 | 0.010 |
Why?
|
| Lac Operon | 1 | 1997 | 238 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 1998 | 390 | 0.010 |
Why?
|
| Kynurenic Acid | 1 | 1997 | 46 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 23338 | 0.010 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2002 | 952 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39050 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 1997 | 176 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3701 | 0.010 |
Why?
|
| Animals | 4 | 2002 | 168757 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1998 | 1137 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 916 | 0.010 |
Why?
|
| Astrocytes | 1 | 2002 | 1270 | 0.010 |
Why?
|
| Glycine | 1 | 1997 | 671 | 0.010 |
Why?
|
| Microglia | 1 | 2002 | 1266 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 1997 | 1056 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2002 | 3798 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1997 | 1701 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 1998 | 2077 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4420 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 9734 | 0.010 |
Why?
|
| Transfection | 1 | 1997 | 5892 | 0.010 |
Why?
|
| Kinetics | 1 | 1997 | 6473 | 0.010 |
Why?
|
| Mitochondria | 1 | 1998 | 3520 | 0.000 |
Why?
|
| Calcium | 1 | 1998 | 5756 | 0.000 |
Why?
|
| Cell Line | 1 | 1997 | 15997 | 0.000 |
Why?
|
| Kidney | 1 | 1997 | 7186 | 0.000 |
Why?
|
| Brain | 1 | 2002 | 26385 | 0.000 |
Why?
|
| Signal Transduction | 1 | 1998 | 23403 | 0.000 |
Why?
|
| Mice | 1 | 2002 | 81183 | 0.000 |
Why?
|